Delivering medicine to the world's poorest people is a challenge. Hot, poor places such as Tanzania have many microbes but microscopic health budgets. Because they cannot afford adequate health care, poor people are sick a lot of time (The economist, 17/8/2002). Another report by the UNAIDS published in 1988 says, "Access to even the most basic drugs is seriously lacking in the Third World". All these statements unanimously assert that, in effect, that there is a serious shortage of widespread medical supplies in the Third World. In addition, as it was mentioned in the Economist (2001, p.75), rich countries have no problems with sharing their diseases but they are quite reluctant to share their wealth. They have transmitted infections such as tuberculosis to developing countries very "easily" but it was not so straightforward for them to share the pharmaceutical solutions to those infections. In these Third World countries, such as South Africa, there is a complete lack of medical supplies being dispersed equally, but if this were any different, then maybe we would not have a Third World as a consequence.
[...] The aid organisations and services involved are unrecognisable when it comes to these countries being helped out. However, would that be enough for the Third World or would it simply enable developing countries to catch up in the field of medicine? Developed countries move on technologically and medically whilst the developing countries are held back, the gap seemingly getting wider, and therefore less and less possible to overcome. As Research and Development contributes to maintain a continuing gap, we can remain a bit skeptical BIBLIOGRAPHY Books Alder, M.W. [...]
[...] An example being technology in this case, as drugs are not evenly spread in developed countries. AVERT (n.d., mentioned this notion through an example regarding the USA, where poor, uninsured people have no access to treatment. One can also comment that it is no longer simply a money problem. The level of education very often determines the level of health in a country, as the rules of basic hygiene are taught in every primary educational establishment, and in addition there exists a constant relationship between the level of education, hygiene and life expectancy. [...]
[...] Spilker, B. (1994). Multinational pharmaceutical companies: principles and practices second edition, New York: Raven Press. Whaley, R.F. & Talal J. Hashim, T.J. (1995). A textbook of world health: a practical guide to global health care. Carnforth: Parthenon. Articles A war over drugs and patents. (2001, March 10). The Economist, p.75- 76. Follow my lead. [...]
[...] (n.d.). Essential drugs and medicines policy. Retrieved November from http://www.who.int/medicines World Health Organisation (WHO). (2004, March 18). South Africa: cautious optimism over AIDS drug rollout. Retrieved November from UNAIDS Web site: http://www.unaids.org/EN/other/functionalities/Search.asp World Health Organisation (WHO). (2004, April 9). South Africa: Special report on a decade of democracy HIV/AIDS. [...]
[...] In fact, the cost of the actual process of producing these tablets in large quantities is very low but the amount of money required for the development and testing of new drugs is much higher. In addition, transport and supply problems cannot be forgotten. It is essential that people have access to an endless quantity of drugs but in some isolated areas it can be very difficult. Of course, local production can make it easier for people to have access to the medicines they need but sometimes drugs have to be kept refrigerated while they are transported and until they are used which can create transport difficulties in particular for isolated and poor areas. [...]
Source aux normes APA
Pour votre bibliographieLecture en ligne
avec notre liseuse dédiée !Contenu vérifié
par notre comité de lecture